Home » Health » We could have the cancer and HIV vaccine because of the findings for the COVID vaccine

We could have the cancer and HIV vaccine because of the findings for the COVID vaccine

It is said that in any crisis there is an opportunity. Medical progress during the coronavirus pandemic could be a chance to treat some chronic diseases for which there is no solution so far. Scientists are experimenting with how they could use messenger RNA technology – developed in COVID vaccines – to treat terminal diseases such as cancer and HIV.

The coronavirus pandemic prompted scientists to create a first vaccine using ARN mesager, a small particle in the spike protein of the coronavirs, to create a response of the immune system that protects us from infection, according to Insider.

It is a vaccine approach that researchers have been studying for 25 years.

After effective clinical trials and millions of vaccinated with the messenger RNA technique against COVID-19, scientists now want to find a way to apply this type of treatment to other conditions.

The messenger RNA technique is used in anti-COVID vaccines produced by Pfizer and Moderna.

The messenger RNA technique could be used to create a cancer vaccine

Experts at the University of Texas Anderson Cancer Center are preparing to study messenger RNA as a treatment option for cancer.

They believe that messenger RNA could be used to prevent the recurrence of cancer, according to oncologist Van Morris.

The likelihood of malignancies recurring varies depending on the type of cancer and most frequently recurrence in ovarian cancer, of the bladder and al glioblastomului.

Recurrence is when small amounts of cancer cells remain in the body after treatment, multiply and in some cases move to other areas of the body.

In this study, which is currently in its second phase, doctors are testing cancer patients who have had tumors removed and have had chemotherapy. Once tests show that cancer cells are still circulating in the body, researchers create individualized messenger RNA cocktails for each patient.

“We hope that through personalized vaccines we will activate the immune system to attack the cancer cells left in the body, so that they can be eliminated and cure the patient,” says Morris.

Researchers hope to develop HIV vaccine thanks to findings during COVID-19

Researchers at Scripps University in California are checking whether HIV, a sexually transmitted virus that affects 1.2 million people worldwide, could be a candidate for the messenger RNA vaccine.

Similar to how COVID-19 attaches to spike coronavirus proteins and kills them, the HIV vaccine could have the same HIV particles, says William Schief, an immunologist at Scripps, who helped develop the HIV vaccine in the first place. phase of the study.

Now that scientists know that messenger RNA can locate and kill HIV, they will use this technology in future studies in hopes of creating an HIV vaccine.

Oxford University specialists who worked with AstraZeneca on the COVID vaccine are now working on a vaccine to treat gonorrhea, a sexually transmitted disease.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.